These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32242801)

  • 1. Smoking and systemic sclerosis: influence on microangiopathy and expression of anti-topoisomerase I antibodies in a monocentric cohort.
    Ciaffi J; van Leeuwen NM; Huizinga TWJ; de Vries-Bouwstra JK
    Clin Exp Rheumatol; 2020; 38 Suppl 125(3):25-28. PubMed ID: 32242801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort.
    Ciaffi J; Liem SIE; Cannegieter S; Ahmed S; Hoekstra EM; Wiland P; Atsumi T; Szücs G; Balbir Gurman A; Czirják L; Zanatta E; Koetter I; Henes JC; Matucci-Cerinic M; Airò P; Ursini F; Huizinga TWJ; De Vries-Bouwstra J; Collaborators E
    RMD Open; 2024 May; 10(2):. PubMed ID: 38772679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Centromere- and Topoisomerase-specific Immune Responses and the Degree of Microangiopathy in Systemic Sclerosis.
    van Leeuwen NM; Wortel CM; Fehres CM; Bakker JA; Scherer HU; Toes REM; Huizinga TWJ; de Vries-Bouwstra JK
    J Rheumatol; 2021 Mar; 48(3):402-409. PubMed ID: 32482649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis.
    Sulli A; Ruaro B; Smith V; Pizzorni C; Zampogna G; Gallo M; Cutolo M
    J Rheumatol; 2013 May; 40(5):634-9. PubMed ID: 23457379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High anti-topoisomerase-1 autoantibodies levels are associated with the extension of skin fibrosis and vascular progression in patients with systemic sclerosis].
    Dol C; Granel B; Resseguier N; Kaplanski G; Reynaud-Gaubert M; Schleinitz N; Grob JJ; Delaporte E; Lafforgue P; Rossi P; Bardin N; Benyamine A
    Rev Med Interne; 2024 Mar; 45(3):126-131. PubMed ID: 38355359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis.
    Pizzorni C; Giampetruzzi AR; Mondino C; Facchiano A; Abeni D; Paolino S; Ruaro B; Smith V; Sulli A; Cutolo M
    Microvasc Res; 2017 May; 111():20-24. PubMed ID: 27989404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts.
    Liem SIE; Boonstra M; le Cessie S; Riccardi A; Airo P; Distler O; Matucci-Cerinic M; Caimmi C; Siegert E; Allanore Y; Huizinga TWJ; Toes REM; Scherer HU; de Vries-Bouwstra JK;
    Lancet Rheumatol; 2022 Oct; 4(10):e699-e709. PubMed ID: 38265968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoking is not a risk factor for systemic sclerosis.
    Chaudhary P; Chen X; Assassi S; Gorlova O; Draeger H; Harper BE; Gonzalez E; McNearney T; Perry M; Arnett FC; Mayes MD
    Arthritis Rheum; 2011 Oct; 63(10):3098-102. PubMed ID: 21647865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies.
    Liem SIE; Neppelenbroek S; Fehres CM; Wevers BA; Toes REM; Allaart CF; Huizinga TWJ; Scherer HU; De Vries-Bouwstra JK
    RMD Open; 2023 Feb; 9(1):. PubMed ID: 36746531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques.
    Ruaro B; Sulli A; Smith V; Pizzorni C; Paolino S; Alessandri E; Cutolo M
    Reumatismo; 2017 Dec; 69(4):147-155. PubMed ID: 29320840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies.
    Markusse IM; Meijs J; de Boer B; Bakker JA; Schippers HPC; Schouffoer AA; Ajmone Marsan N; Kroft LJM; Ninaber MK; Huizinga TWJ; de Vries-Bouwstra JK
    Rheumatology (Oxford); 2017 Jul; 56(7):1081-1088. PubMed ID: 27940596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
    Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
    Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.
    Iniesta Arandia N; Simeón-Aznar CP; Guillén Del Castillo A; Colunga Argüelles D; Rubio-Rivas M; Trapiella Martínez L; García Hernández FJ; Sáez Comet L; Egurbide Arberas MV; Ortego-Centeno N; Freire M; Marí Alfonso B; Vargas Hitos JA; Ríos Blanco JJ; Todolí Parra JA; Rodríguez-Carballeira M; Marín Ballvé A; Chamorro Fernández AJ; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Espinosa G;
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):98-105. PubMed ID: 28980912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes.
    Clark KEN; Campochiaro C; Host LV; Sari A; Harvey J; Denton CP; Ong VH
    Sci Rep; 2022 Jul; 12(1):11212. PubMed ID: 35780179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
    Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced microvascular damage associated with occurence of sarcopenia in systemic sclerosis patients: results from a retrospective cohort study.
    Paolino S; Goegan F; Cimmino MA; Casabella A; Pizzorni C; Patanè M; Schenone C; Tomatis V; Sulli A; Gotelli E; Smith V; Cutolo M
    Clin Exp Rheumatol; 2020; 38 Suppl 125(3):65-72. PubMed ID: 32167878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early systemic sclerosis-opportunities for treatment.
    Sakkas LI; Simopoulou T; Katsiari C; Bogdanos D; Chikanza IC
    Clin Rheumatol; 2015 Aug; 34(8):1327-31. PubMed ID: 25711876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.
    Trapiella-Martínez L; Díaz-López JB; Caminal-Montero L; Tolosa-Vilella C; Guillén-Del Castillo A; Colunga-Argüelles D; Rubio-Rivas M; Iniesta-Arandia N; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas-Hitos JA; Ríos-Blanco JJ; Todolí-Parra JA; Rodríguez-Carballeira M; Marín-Ballvé A; Chamorro-Fernández AJ; Pla-Salas X; Madroñero-Vuelta AB; Ruiz-Muñóz M; Fonollosa-Pla V; Simeón-Aznar CP;
    Autoimmun Rev; 2017 Aug; 16(8):796-802. PubMed ID: 28564618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
    Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.